F.D.A. advisers voted that the benefits of a nonprescription pill outweigh the risks. If the agency decides to move on the recommendation, the progestin-only contraceptive could be in stores within a few months.
The first U.S. application for sale of a nonprescription birth control pill has taken on new meaning in the wake of the Supreme Court decision ending the constitutional right to abortion.